A Novel Influenza Virus Hemagglutinin-Respiratory Syncytial Virus (RSV) Fusion Protein Subunit Vaccine against Influenza and RSV

Baculovirus-based Vaccine Displaying Respiratory Syncytial Virus Glycoprotein Induces Protective Immunity against RSV Infection without Vaccine-Enhanced Disease

(2012) Sol Kim et al.   Immune Network

A review of palivizumab and emerging therapies for respiratory syncytial virus

(2011) Kristin A Shadman et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Nanobodies® Specific for Respiratory Syncytial Virus Fusion Protein Protect Against Infection by Inhibition of Fusion

(2011) Bert Schepens et al.   JOURNAL OF INFECTIOUS DISEASES

Comparative Pathology in Ferrets Infected with H1N1 Influenza A Viruses Isolated from Different Hosts

(2011) J. H. Smith et al.   JOURNAL OF VIROLOGY

Identification of nucleolin as a cellular receptor for human respiratory syncytial virus

(2011) Farnoosh Tayyari et al.   NATURE MEDICINE

Cold-Adapted Influenza and Recombinant Adenovirus Vaccines Induce Cross-Protective Immunity against pH1N1 Challenge in Mice

(2011) Mark R. Soboleski et al.   PLoS One

Aerosol vaccination induces robust protective immunity to homologous and heterologous influenza infection in mice

(2011) Jennifer Humberd Smith et al.   VACCINE

Aerosol Inoculation with a Sub-lethal Influenza Virus Leads to Exacerbated Morbidity and Pulmonary Disease Pathogenesis

(2011) Jennifer Humberd Smith et al.   VIRAL IMMUNOLOGY

Influenza Hemagglutinin and Neuraminidase Membrane Glycoproteins

(2010) Steven J. Gamblin et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine

(2010) Davide Corti et al.   JOURNAL OF CLINICAL INVESTIGATION

Pandemic influenza A(H1N1) 2009 and respiratory syncytial virus associated hospitalizations

(2010) Fernando Lovato-Salas et al.   JOURNAL OF INFECTION

Novel Inhibitors of Influenza Virus Fusion: Structure-Activity Relationship and Interaction with the Viral Hemagglutinin

(2010) E. Vanderlinden et al.   JOURNAL OF VIROLOGY

Respiratory Syncytial Virus-Neutralizing Monoclonal Antibodies Motavizumab and Palivizumab Inhibit Fusion

(2010) K. Huang et al.   JOURNAL OF VIROLOGY

Prophylactic Treatment with a G Glycoprotein Monoclonal Antibody Reduces Pulmonary Inflammation in Respiratory Syncytial Virus (RSV)-Challenged Naive and Formalin-Inactivated RSV-Immunized BALB/c Mice

(2010) G. U. Radu et al.   JOURNAL OF VIROLOGY

Expansion of seasonal influenza vaccination in the Americas

(2009) Alba María Ropero-Álvarez et al.   BMC PUBLIC HEALTH

Treatment with respiratory syncytial virus G glycoprotein monoclonal antibody or F(ab')2 components mediates reduced pulmonary inflammation in mice

(2009) C. Miao et al.   JOURNAL OF GENERAL VIROLOGY

Vaccination To Induce Antibodies Blocking the CX3C-CX3CR1 Interaction of Respiratory Syncytial Virus G Protein Reduces Pulmonary Inflammation and Virus Replication in Mice

(2009) W. Zhang et al.   JOURNAL OF VIROLOGY

Severe Respiratory Disease Concurrent with the Circulation of H1N1 Influenza

(2009) Gerardo Chowell et al.   NEW ENGLAND JOURNAL OF MEDICINE

Relative Impact of Influenza and Respiratory Syncytial Virus in Young Children

(2009) F. T. Bourgeois et al.   PEDIATRICS

Respiratory Syncytial Virus Proteins Modulate Suppressors of Cytokine Signaling 1 and 3 and the Type I Interferon Response to Infection by a Toll-Like Receptor Pathway

(2009) Christine M. Oshansky et al.   VIRAL IMMUNOLOGY

Cross-Protection against Lethal H5N1 Challenge in Ferrets with an Adjuvanted Pandemic Influenza Vaccine

(2008) Benoît Baras et al.   PLoS One

Influenza viruses and the evolution of avian influenza virus H5N1

(2007) Nedaa Skeik et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES